nicorandil has been researched along with ST Elevation Myocardial Infarction in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 6 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Geng, N; Pang, W; Ren, L; Xu, L; Zou, D | 1 |
| Gao, W; Ge, J; Huang, D; Ma, Y; Qian, J; Wu, H; Zhong, X; Zhou, J | 1 |
| Li, P; Li, Y; Liang, X; Liao, W; Lin, Z; Liu, M; Xie, W | 1 |
| Ahn, J; Cha, KS; Choe, JC; Choi, JH; Kim, E; Kim, MS; Lee, HC; Lee, HW; Lee, JW; Oh, JH; Park, JH; Park, JS; Park, TS | 1 |
| Chen, J; Li, H; Li, P; Liang, XW; Liao, W; Liu, M; Wang, ZD; Zhu, XZ | 1 |
| An, S; Huang, H; Jiang, Y; Wang, H | 1 |
| Chen, T; Jiang, Z; Niu, J; Qi, Q; Wang, T; Yin, H | 1 |
| Chen, YG; He, DY; Luan, FY; Wei, SJ; Xu, F | 1 |
| Duan, Y; Feng, X; Liu, L; Man, W; Shi, Z; Sun, D; Wang, B; Wang, H; Wang, S; Xia, C; Zhao, Z | 1 |
| Mori, H; Sasai, M; Sato, T; Sone, H; Suzuki, H; Takei, Y; Tashiro, K | 1 |
1 review(s) available for nicorandil and ST Elevation Myocardial Infarction
| Article | Year |
|---|---|
Clinical outcomes of nicorandil administration in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials.
Topics: Administration, Intravenous; Aged; Coronary Circulation; Female; Humans; Male; Middle Aged; Nicorandil; No-Reflow Phenomenon; Percutaneous Coronary Intervention; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; ST Elevation Myocardial Infarction; Treatment Outcome; Vasodilator Agents | 2021 |
5 trial(s) available for nicorandil and ST Elevation Myocardial Infarction
| Article | Year |
|---|---|
Intravenous nicorandil during primary percutaneous coronary intervention in patients with ST-Elevation myocardial infarction: Rationale and design of the Clinical Efficacy and Safety of Intravenous Nicorandil (CLEAN) trial.
Topics: Administration, Intravenous; Humans; Nicorandil; Percutaneous Coronary Intervention; ST Elevation Myocardial Infarction; Treatment Outcome | 2022 |
The effect of nicorandil on cardiac function and clinical outcomes in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: a randomised trial.
Topics: Humans; Myocardial Infarction; Nicorandil; Percutaneous Coronary Intervention; Prospective Studies; ST Elevation Myocardial Infarction; Treatment Outcome | 2023 |
Prophylactically injection of Nicorandil to reduce no-reflow phenomenon during PCI in acute STEMI patients: Protocol of a double-blinded, randomized, placebo-controlled trial.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Injections; Male; Middle Aged; Nicorandil; No-Reflow Phenomenon; Percutaneous Coronary Intervention; Randomized Controlled Trials as Topic; ST Elevation Myocardial Infarction; Treatment Outcome; Vasodilator Agents; Young Adult | 2021 |
Intracoronary Nicorandil and the Prevention of the No-Reflow Phenomenon During Primary Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction.
Topics: Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicorandil; No-Reflow Phenomenon; Percutaneous Coronary Intervention; ST Elevation Myocardial Infarction | 2018 |
Sustained nicorandil administration reduces the infarct size in ST-segment elevation myocardial infarction patients with primary percutaneous coronary intervention.
Topics: Administration, Oral; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Nicorandil; Percutaneous Coronary Intervention; Prospective Studies; ST Elevation Myocardial Infarction; Treatment Outcome; Vasodilator Agents | 2019 |
4 other study(ies) available for nicorandil and ST Elevation Myocardial Infarction
| Article | Year |
|---|---|
CoO Nanoparticles Combined with MRI: Analysis of No-Reflow in Patients with Acute ST-Segment Elevation Myocardial Infarction after PCI and the Effect of Coronary Nicorandil.
Topics: Arrhythmias, Cardiac; Humans; Magnetic Resonance Imaging; Myocardial Infarction; Nanoparticles; Nicorandil; Percutaneous Coronary Intervention; ST Elevation Myocardial Infarction; Treatment Outcome | 2022 |
Effect of intravenous application of nicorandil on area of myocardial infarction in patients with STEMI during the perioperative stage of PCI.
Topics: Administration, Intravenous; Antihypertensive Agents; Female; Humans; Male; Middle Aged; Nicorandil; Percutaneous Coronary Intervention; Perioperative Period; ST Elevation Myocardial Infarction; Treatment Outcome | 2021 |
Intracoronary administration of nicorandil-induced cardiac arrest during primary percutaneous coronary intervention: A case report.
Topics: Aged; Heart Arrest; Humans; Male; Nicorandil; Percutaneous Coronary Intervention; ST Elevation Myocardial Infarction; Vasodilator Agents | 2019 |
Polygon-like luminal configuration captured by intracoronary optical frequency domain imaging of a spontaneous coronary spasm in an ST-elevation myocardial infarction patient.
Topics: Coronary Angiography; Coronary Vasospasm; Coronary Vessels; Drug-Eluting Stents; Humans; Male; Middle Aged; Nicorandil; Percutaneous Coronary Intervention; Predictive Value of Tests; ST Elevation Myocardial Infarction; Tomography, Optical Coherence; Treatment Outcome; Vasoconstriction; Vasodilator Agents | 2019 |